secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2023-10-24T23:59:59+00:00
Accession:  0001157523-23-001529
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q3 net sales $213M, EPS $0.59; narrows FY 2023 guidance
-------------------------------------------------------------

- Q3 net sales $213M (-9% YoY); diluted EPS $0.59 (-24% YoY).
- Active customers 464,000 (-2% YoY); Asia Pacific region sales $170M (-7% YoY).
- Greater China net sales $107M (-3% YoY, +2% constant currency); active customers +8%.
- FY 2023 outlook narrowed: net sales $900-$920M, EPS $2.80-$3.05 (prev. $900-$950M, $2.65-$3.30).
- Repurchased 180K shares for $12M; ended quarter debt-free with $307M cash.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752323001529/0001157523-23-001529-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752323001529/a53675959.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-001529

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer